Dan Paterson
Chief Executive Officer at VERASTEM, INC.
Net worth: 404 069 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Calkins | M | 37 | 6 years | |
| Michael Kauffman | M | 60 | 12 years | |
| Brian Stuglik | M | 64 | 7 years | |
| Eric Rowinsky | M | 67 | 7 years | |
| John Johnson | M | 66 | 4 years | |
| Cathy Carew | F | - | - | |
| Paul Bunn | M | 79 | 3 years | |
| Anil Kapur | M | 54 | 2 years | |
| Robert Gagnon | M | 49 | 6 years | |
| Michelle Robertson | F | 57 | 3 years | |
| David Mitchell | M | 67 | 1 years | |
| Hagop Youssoufian | M | 67 | 7 years | |
| Jonathan Pachter | M | 66 | 13 years | |
| Karin Tollefson | M | 57 | 1 years | |
| Michael Crowther | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert M. Forrester | M | 60 | 8 years | |
| Joseph Chiapponi | M | 55 | 6 years | |
| Paul Brannelly | M | 51 | 3 years | |
| Mara Aspinall | F | 61 |
On-Q-ity, Inc.
 On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | 5 years |
| Richard H. Aldrich | M | 69 | 4 years | |
| Stephen Sherwin | M | 75 | 3 years | |
| Paul Friedman | M | 81 | 3 years | |
| Lesley Solomon | F | 52 | 2 years | |
| Sean Flynn | M | 50 | 1 years | |
| Alison Lawton | F | 62 | 8 years | |
| Stephen Kraus | M | 47 | 2 years | |
| John Doyle | M | 46 | 2 years | |
| Alan D. D'Andrea | M | - |
The DNA Repair Co.
 The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | - |
| Brian Sullivan | M | - | 9 years | |
| Gina Consylman | F | 52 | 3 years | |
| Ansbert Gadicke | M | 66 | 2 years | |
| Bruce Wendel | M | 70 | 5 years | |
| Henri A. Termeer | M | 78 | 5 years | |
| S. Phanstiel | F | 65 | 6 years | |
| Timothy Barberich | M | 76 | 8 years | |
| Peter A. Pellegrino | M | 49 | 1 years | |
| Madelyn Zeylikman | F | - | - | |
| Michael Ferraresso | M | - | - | |
| Julie Feder | F | 54 | 1 years | |
| NgocDiep Le | M | 56 | 1 years | |
| Frank Neumann | M | - | - | |
| Kirk Taylor | M | - | 1 years | |
| Shawn Leland | M | 40 | 2 years | |
| Ajay Munshi | M | - | - | |
| Tiffany Burt | F | - | 1 years | |
| Jessica Christo | F | - | 2 years | |
| Lisa Buffington | F | - | 4 years | |
| Robert Morgan | M | - | 1 years | |
| Michael B. Yaffe | M | - |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | - |
| Gary Palmer | M | - |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | 2 years |
| Michael Goldberg | M | 66 |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | - |
| Joseph Lobacki | M | 65 | 1 years | |
| Monica Singh Kleinman | F | - | - | |
| William A. Haseltine | M | 79 |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | - |
| Joanna Horobin | M | 69 | 3 years | |
| John Green | M | 43 | 3 years | |
| Louis Vaickus | M | - | - | |
| Steven Bloom | M | 63 | 5 years | |
| Dion Madsen | M | 56 |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | 5 years |
| Amy Pernell Cavers | F | - | 1 years | |
| Scott A. Holmes | M | 50 |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | 1 years |
| Gregory Berk | M | 66 | 1 years | |
| Marcus Grompe | M | - |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | - |
| Brian E. Ward | M | 71 |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | - |
| David T. Weaver | M | - |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | - |
| Stella Quan | M | - |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | - |
| Erin S. Cox | F | - | - | |
| Louis J. Denis | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 68 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dan Paterson
- Personal Network
